About Cooke Pharma
Cooke Pharma is a company based in Belmont (United States) founded in 1995 was acquired by United Therapeutics in December 2000.. Cooke Pharma has raised $12.5 million across 1 funding round from investors including United Therapeutics, Sherbrooke Capital and Johnson & Johnson Innovation – JJDC. Cooke Pharma operates in a competitive market with competitors including GOLO, Provexis, Calroy, Lycodha and Essential IP, among others.
- Headquarter Belmont, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.5 M (USD)
in 1 rounds
-
Latest Funding Round
$12.5 M (USD), Series A
Nov 01, 1999
-
Investors
United Therapeutics
& 2 more
-
Employee Count
Employee Count
-
Acquired by
United Therapeutics
(Dec 18, 2000)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cooke Pharma
Cooke Pharma has successfully raised a total of $12.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $12.5 million completed in November 1999. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $12.5M
-
First Round
First Round
(01 Nov 1999)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 1999 | Amount | Series A - Cooke Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cooke Pharma
Cooke Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include United Therapeutics, Sherbrooke Capital and Johnson & Johnson Innovation – JJDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Treatments for chronic and life-threatening diseases are developed and commercialized.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cooke Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cooke Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cooke Pharma Comparisons
Competitors of Cooke Pharma
Cooke Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GOLO, Provexis, Calroy, Lycodha and Essential IP, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Dietary supplements for weight loss are provided by GOLO.
|
|
| domain | founded_year | HQ Location |
Manufacturing and marketing a tomato extract for reducing propensity for aberrant blood clotting
|
|
| domain | founded_year | HQ Location |
Develops and sells science-backed supplements for vascular, joint, and oral health.
|
|
| domain | founded_year | HQ Location |
Creates innovative supplements to support cardiovascular health.
|
|
| domain | founded_year | HQ Location |
Develops nutraceuticals to support cardiovascular health.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cooke Pharma
When was Cooke Pharma founded?
Cooke Pharma was founded in 1995 and raised its 1st funding round 4 years after it was founded.
Where is Cooke Pharma located?
Cooke Pharma is headquartered in Belmont, United States. It is registered at Belmont, California, United States.
Is Cooke Pharma a funded company?
Cooke Pharma is a funded company, having raised a total of $12.5M across 1 funding round to date. The company's 1st funding round was a Series A of $12.5M, raised on Nov 01, 1999.
What does Cooke Pharma do?
Cooke Pharma was founded in 1995 and is located in Belmont, United States. Operations center on the pharmaceutical sector, specifically the development of medical foods targeting angina and other cardiovascular conditions. The HeartBar product, recognized as the first FDA-approved medical food for these indications, is produced to address heart disease symptoms by expanding blood vessel diameter and improving blood flow. Focus remains on therapeutic nutrition for cardiovascular health.
Who are the top competitors of Cooke Pharma?
Who are Cooke Pharma's investors?
Cooke Pharma has 3 investors. Key investors include United Therapeutics, Sherbrooke Capital, and Johnson & Johnson Innovation – JJDC.